Shimadzu Corporation Stock

Equities

7701

JP3357200009

Office Equipment

Market Closed - Japan Exchange 02:00:00 2024-05-24 am EDT 5-day change 1st Jan Change
4,219 JPY -0.73% Intraday chart for Shimadzu Corporation -3.21% +7.03%
Sales 2024 512B 3.26B Sales 2025 * 528B 3.36B Capitalization 1,243B 7.92B
Net income 2024 57.04B 363M Net income 2025 * 56.94B 363M EV / Sales 2024 2.44 x
Net cash position 2024 * 194B 1.24B Net cash position 2025 * 173B 1.1B EV / Sales 2025 * 2.03 x
P/E ratio 2024
21.9 x
P/E ratio 2025 *
21.6 x
Employees 14,219
Yield 2024
1.42%
Yield 2025 *
1.45%
Free-Float 97.53%
More Fundamentals * Assessed data
Dynamic Chart
Shimadzu Corporation announces an Equity Buyback for 12,500,000 shares, representing 4.24% for ¥25,000 million. CI
Shimadzu Corporation authorizes a Buyback Plan. CI
Shimadzu Corporation acquired Gas chromatograph (GC) catalytic microreactor Business from Activated Research Company, LLC. CI
Certain Common Stock of AR advanced technology, Inc. are subject to a Lock-Up Agreement Ending on 19-DEC-2023. CI
MiCAN Technologies Inc. announced that it has received ¥200 million in funding from RealTechJapan LLC., Fujimori Kogyo Co., Ltd., Shimadzu Corporation CI
IMMUNOSENS Co. Ltd. announced that it has received funding from Global Brain Co., Ltd., Shimadzu Corporation CI
AR advanced technology, Inc. has completed an IPO in the amount of ¥924.21 million. CI
Shyld AI and Shimadzu Corporation Team Up with the Goal of Revolutionizing Healthcare with Groundbreaking AI-Powered UV-C Disinfection Technology CI
Jefferies Adjusts Shimadzu's Price Target to 5,500 Yen From 5,000 Yen, Keeps at Buy MT
Shimadzu Corporation acquired Biomaneo. CI
AR advanced technology, Inc. has filed an IPO. CI
Shimadzu Corporation Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Jefferies Adjusts Shimadzu's Price Target to 5,000 Yen From 5,500 Yen, Keeps at Buy MT
New entries in the Asia Investor Portfolio Our Logo
Shimadzu Corp. Shares Rise on Higher First-Half Profit DJ
More news
1 day-0.73%
1 week-4.05%
Current month-2.13%
1 month+1.66%
3 months+8.63%
6 months+9.58%
Current year+7.03%
More quotes
1 week
4 219.00
Extreme 4219
4 399.00
1 month
4 146.00
Extreme 4146
4 612.00
Current year
3 745.00
Extreme 3745
4 612.00
1 year
3 493.00
Extreme 3493
4 637.00
3 years
3 493.00
Extreme 3493
5 550.00
5 years
2 148.00
Extreme 2148
5 550.00
10 years
856.00
Extreme 856
5 550.00
More quotes
Managers TitleAgeSince
Director of Finance/CFO - -
President 65 83-03-31
Chairman 67 82-03-31
Members of the board TitleAgeSince
Director/Board Member 71 20-05-31
Comptroller/Controller/Auditor 69 81-03-31
Director/Board Member 69 21-05-31
More insiders
Date Price Change Volume
24-05-24 4,219 -0.73% 554,800
24-05-23 4,250 -0.72% 420,200
24-05-22 4,281 -0.63% 646,000
24-05-21 4,308 -0.97% 481,800
24-05-20 4,350 -0.21% 495,700

Delayed Quote Japan Exchange, May 24, 2024 at 02:00 am EDT

More quotes
Shimadzu Corp is a Japan-based company mainly engaged in the research, development, manufacture, sale and maintenance of scientific and precision equipment. The Company has four segments. Testing and Measuring Instruments segment is engaged in the provision of chromatographic analysis systems, mass spectrometry systems, light analysis systems, thermal analysis systems, bio-related analysis systems, water quality measurement systems and others. Medical Equipment segment is engaged in the provision of X-ray television (TV) systems, angiography systems, X-ray imaging systems and others. Aircraft Equipment segment is engaged in the provision of flight control systems, air management systems, cockpit display systems and others. Industrial Equipment segment is engaged in the provision of turbomolecular pumps and others. The Company is also engaged in the leasing and management of real estate business.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
4,219 JPY
Average target price
5,206 JPY
Spread / Average Target
+23.39%
Consensus